ConductScience.org, home

Trial · NCT07898852

Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in internalized stigma (ISMI total score)Baseline (before randomization) and post-intervention (Week 8)Internalized stigma measured with the Internalized Stigma of Mental Illness (ISMI) scale, Turkish version (29 items, 4-point Likert scale). Higher scores indicate greater internalized stigma.
SecondaryChange in self-esteem (RSES)Baseline and post-intervention (Week 8)Self-esteem measured with the Rosenberg Self-Esteem Scale (RSES), Turkish version. Lower scores indicate higher self-esteem.
SecondaryChange in hopelessness (BHS-7)Baseline and post-intervention (Week 8)Hopelessness measured with the 7-item short form of the Beck Hopelessness Scale (BHS-7), Turkish version. Higher scores indicate greater hopelessness.
SecondaryChange in psychological flourishing (Flourishing Scale)Baseline and post-intervention (Week 8)
Psychological flourishing measured with the Flourishing Scale (Diener et al., 2010), Turkish version (Psychological Well-Being Scale; Telef, 2013) (8 items, 7-point Likert scale; total score 8-56). Higher scores indicate greater psychological flourishing.
SecondaryInternalized stigma at 3-month follow-up (ISMI)Baseline, post-intervention (Week 8), and 3 months after the post-testISMI total score at 3-month follow-up compared with baseline and post-intervention.
SecondarySelf-esteem at 3-month follow-up (RSES)Baseline, post-intervention (Week 8), and 3 months after the post-testRSES score at 3-month follow-up compared with baseline and post-intervention.
SecondaryHopelessness at 3-month follow-up (BHS-7)Baseline, post-intervention (Week 8), and 3 months after the post-testBHS-7 score at 3-month follow-up compared with baseline and post-intervention.
SecondaryPsychological flourishing at 3-month follow-up (Flourishing Scale)Baseline, post-intervention (Week 8), and 3 months after the post-testFlourishing Scale score at 3-month follow-up compared with baseline and post-intervention.
SecondarySession attendance rateWeeks 1-8Mean percentage of the 8 sessions attended by participants in the intervention group.
SecondaryProgram completion rateWeeks 1-8Percentage of participants in the intervention group who attend at least 6 of the 8 sessions.
SecondaryAssessment retention ratePost-intervention (Week 8) and 3-month follow-upPercentage of randomized participants in each group who complete the post-intervention and 3-month follow-up assessments.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07898852/registered